Syringe Units = Volume to Draw (mL) 100 = 0.25 mL 100 = 25 units TB-500 Dosing Profile (10 mg Vial / 1 mL BAC Water) 2.5 mg Dose: Draw 25 units (0.25 mL)
GLOW KLOW Components BPC-157, TB-500, GHK-Cu BPC-157, TB-500, GHK-Cu, KPV Peptide count 3 4 Common vial size 70 mg 80 mg Typical label split GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg / KPV 10mg Distinguishing component KPV, the C-terminal tripeptide of alpha-MSH, studied for anti-inflammatory activity In other words, KLOW is GLOW plus KPV
[PMID: 33092650] PubMed record related to this compound for laboratory literature review
The standard 12-week escalation from 0.6mg to 2.4mg weekly balances efficacy with tolerability, producing 10-12% weight loss for most users
Reduced caloric intake can contribute, especially if the appetite suppression leads to unintentionally skipping meals